What clinical trials are available for recurrent Head and Neck Cancer

Head and Neck CancerMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Clinical Trials for Recurrent Head and Neck Cancer

I appreciate your question about clinical trial options for recurrent head and neck cancer. This is an important area where clinical trials can offer access to newer treatment approaches when standard options have been exhausted.

What I Can Tell You

Unfortunately, the medical guidelines provided to me (NCCN Guidelines) focus primarily on central nervous system cancers, thyroid cancer, and lung cancer rather than head and neck cancers specifically. This means I don't have access to the most current, head and neck-specific clinical trial information from my trusted sources to give you a complete answer.

How to Find Clinical Trials for Your Situation

Here are the authoritative resources where you can search for active clinical trials:

Primary Trial Databases:

  • ClinicalTrials.gov (National Institutes of Health) - Search by cancer type, location, and trial phase
  • NCCN Member Institutions - Many comprehensive cancer centers have their own trial databases
  • American Cancer Society - Provides trial-finding resources and information about what to expect
  • Cancer.gov (National Cancer Institute) - Offers trial matching services

When searching, specify:

  • "Recurrent head and neck cancer" or "recurrent squamous cell carcinoma of the head and neck"
  • Your specific cancer location (oral cavity, pharynx, larynx, etc.)
  • Your geographic location or willingness to travel
  • Prior treatments you've received

Questions to Ask Your Oncology Team

Your head and neck cancer specialist is your best resource for trial recommendations because they understand:

  1. Your specific cancer profile - What type of head and neck cancer, stage, and biomarkers (HPV status, PD-L1 expression, etc.)
  2. Your treatment history - What therapies you've already received and how you responded
  3. Your eligibility - Which trials match your medical condition and performance status
  4. Local opportunities - Trials available at your treatment center or nearby institutions

Specific questions to ask:

  • "Are there any clinical trials you would recommend for my recurrent cancer?"
  • "What are the eligibility requirements, and do I qualify?"
  • "How does this trial compare to standard treatment options available to me?"
  • "What are the potential benefits and risks specific to my situation?"
  • "How will my progress be monitored during the trial?"

General Trial Landscape for Recurrent Head and Neck Cancer

While I don't have specific trial details, recurrent head and neck cancers are typically studied in trials examining:

  • Immunotherapy combinations (checkpoint inhibitors)
  • Targeted therapies (based on specific mutations)
  • Combination chemotherapy approaches
  • Radiation therapy innovations
  • Novel drug combinations

The specific trials available to you will depend on your cancer's characteristics and your prior treatment.

Next Steps

  1. Contact your oncologist with a list of questions about available trials
  2. Search ClinicalTrials.gov yourself to see what's available in your area
  3. Ask about tumor testing - Some trials require specific biomarkers that may need to be tested
  4. Request a second opinion from a head and neck cancer specialist at a comprehensive cancer center if you want additional trial recommendations

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: